SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001477932-20-006969
Filing Date
2020-11-30
Accepted
2020-11-30 17:23:51
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 curr_s3.htm S-3 257707
2 OPINION OF K&L GATES LLP curr_ex51.htm EX-5.1 10296
3 CONSENT curr_ex231.htm EX-23.1 3034
4 curr_ex231img2.jpg GRAPHIC 2496
5 curr_ex231img3.jpg GRAPHIC 6575
6 curr_s3img1.jpg GRAPHIC 2727
7 curr_ex51img1.jpg GRAPHIC 2266
  Complete submission text file 0001477932-20-006969.txt   291954
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251039 | Film No.: 201359039
SIC: 2673 Plastics, Foil & Coated Paper Bags